Itanium part of leading cancer research center solution
As Senior Director of Application and Performance Engineering at SGI at Silicon Graphics (SGI), I’ve been part of SGI’s efforts to deliver solutions powered by Intel Xeon and Itanium processors to customers around the world. Recently, we announced plans to outfit a new world-class cancer research facility in the UK. The Institute of Cancer Research in London will rely on SGI systems for groundbreaking work in integrative network biology. Unlike mainstream cancer research, which usually focuses on the structure and behavior of individual genes, proteins or cells, this new field studies how how cancer cells interact within the larger biological network. The research could lead to new drugs or treatments that prevent metastasis – the stage when cancer can turn deadly. Studying the dynamics of cellular networks will generate enormous data sets and involve a wide range of distributed and shared-memory applications, thus requiring a true hybrid solution that addresses both sides of the computational coin.